The importance of alpha-1 antitrypsin (α1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients

Neuroendocrinology Letters

Volumn 31, Issue 1, 2010, Pages 113-116

  El Akawi, Zeyad J ^a   Abu Awad, Aymen M ^b   Sharara, Abdelmonem M ^b   Khader, Yousef S ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

Alpha 1 antitrypsin; Cancer; Lung; Neopterin; Prostate

Indexed keywords

ALPHA 1 ANTITRYPSIN; NEOPTERIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNODIFFUSION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 77749330082     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Amiguet JA, Jimenez J, Monreal JI, Hernandez MJ, Lopez-Vivanco G, Vidan JR, et al. (1998). Serum proteolytic activities and antiproteases in human colorectal carcinoma. J. Physiol. Biochem. 54(1): 9-13.
2. Bata J, Colobert L, Biron A, Brune J. (1977): Study of various serum proteins in lung cancer. Immunoglobulins A, G, M, haptoglobin, alpha-1 antitrypsin, alpha-2 macroglobin. Ann. Biol. Clin. (Paris) 35(4): 297-303.
3. Carrell RW, Jeppson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, et al. (1982). Structure and variation of human alpha-1 antitrypsin. Nature. 298: 329-333.
4. Chio LF, Oon CJ. (1979). Changes in serum alpha-1 antitrypsin, alpha-1 acid glycoprotein and beta-2 glycoprotein-1 in patients with malignant hepatocellular carcinoma. Cancer. 43(2): 596-604.
5. Daddi G, Mancini PA, Parola D, Contini A. (1976). Alpha-antitrypsin increase in lung cancer. Boll Ist Sieroter Milan 55 (6): 510-512.
6. Debrowska M, Mantur M, Panasiuk A, Prokopowicz J. (1997). Does the concentration of alpha-1 proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma? Neoplasma. 44(5): 305-307.
7. deLorimier A, Park F, Aranha GV, Reyes C. (1993). Hepatoid carcinoma of the stomach. Cancer. 71(2): 293-296.
8. Demidove VP, Iakubovskaia RI, Karmakova TA, Avdeev GI, Komissarov AB, Sorokin EE, et al. (1990). Alpha-1 proteinase inhibitor in breast cancer. Vopr. Onkol. 36(1): 23-29.
9. Fuchs D, Weiss G, Reibnegger G, Wachter H. (1992). The role of neopterin as a monitor of Cellular Immune Activation in Transplantation, Inflammatory, Infectious, and Malignnat Diseases. Crit. Rev. Clin. Lab. Sci. 29 (3,4): 307-341.
10. Harris CC, Cohen MH, Connor R, Primack A, Saccomanno G, Talamo RC. (1976). Serum alpha-1 antitrypsin in patients with lung cancer or abnormal sputum cytology. Cancer. 38 (4): 1655-1657.
11. Krecicki T, Leluk M. (1992). Acute phase reactant proteins: an aid to monitoring surgical treatment of laryngeal carcinoma. J. Laryngol. Otol. 106. (7): 613-615.
12. Lewenhaupt A, Ekman B, Eneroth P, Eriksson A, Nilssson B, Nordstrom L. (1986). "Serum levels of neopterin as related to the prognosis of human prostatic carcinoma". Eur. Urol. 12(6): 422-425.
13. Ljungberg B, Grankvist K, Rasmuson T. (1995). Serum acute phase reactant and prognosis in renal cell carcinoma. Cancer. 76(8): 1435-1439.
14. Mattison P, Cove DH, Walsh L, Howell A, McConkey B, Morrison JM. (1981). Serum proteins as tumor markers for breast cancer. Br. J. Cancer. 43(4): 542-545.
15. Merlini G, Perfetti V, Gobbi PG, Quaglini S, Franciotta DM, Marinone G, Ascari E. (1993). Acute phase proteins and prognosis in multiple myeloma. Br. J. Haematol. 84(4): 595-601.
16. Micksche M, Kokron O. (1977). Serum levels of alpha-1 antitrypsin and alpha-2 macroglobulin in lung cancer. Osterr Z Onkol. 3 (5-6): 116-119.
17. Mohamed KH, Mobasher AA, Yousef AR, Salah A, EL-Naggar IZ, Ghoneim AH, et al. (2001). BAL neopterin: a novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer. Chest. 119(3): 776-780.
18. Murr C, Bergant A, Widschwendter M, Heim K, Schrocksnadel H, Fuchs D. (1999). Neopterin is an independent prognsotic variable in female with breast cancer. Clin. Chem. 45(11): 1998-2004.
19. Murr C, Fuith LC, Widner B, Wirleitner B, Baier-bitterlich G, Fuchs D(1999). Increased neopterin concentrations in patients with cancer: indicator of oxidative stress. Anticancer Res. 19(3A): 1721-1728.
20. Patenoster D, Cartei G, Campagnutta E, Maggino T, Valente S, Ongaro G. (1980). Acute reactive stage proteins in gynaecologic cancers. Eur. J. Gynaecol. Oncol. 1(2): 94-98.
21. Pelllinieme TT, Irjala K, Mattila K, Pulkki K, Rajamaki A, Tienhaara A, et al. (1995). Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood. 85(3): 765-771.
22. Pirisi M, Fabris C, Soardo G, Toniutto P, Vitulli D, Bartoli E. (1996). Prognostic value of serum alpha-1 antitrypsin in hepatocellular carcinoma. Eur. J. Cancer. 32A(2): 221-225.
23. Robinaovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH. (1992). Lack of increase in heterozygous alpha-1 antityrpsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Hepatology. 15(3): 407-410.
24. Schena M, Quadri A, Ragazzoni G, Corti P. (1985). Alpha-1 antitrypsin as a tumor marker. Quad. Sclavo. Diagn. 21(1): 87-96.
25. Tountas Y, Sparos L, Theodoropoulos C, Trichopoulos D. (1985). Alpah-1 antitrypsin and cancer of the pancreas. Digestion. 31(1): 37-40.
26. Ward AM, Cooper EH, Houghton AL. (1977). Acute-phase reactant proteins in prostatic cancer. Br. J. Urol. 49(5): 411-418.
27. Yildirim Y, Gunel N, Coskun U, Pasaoglu H, Aslan S, Cetin A. (2008). Serum neopterin levels in patients with breast cancer. Med.Oncol. 25(4): 403-407.
28. Zietek Z, Iwan-Zietek I, Kotschy M, Tyloch F. (1996). Activity of alpha-1 antitrypsin in blood of patients with prostatic tumor. Pol. Tyg. Lek. 51(6-9): 89-90.